Pharmacological inhibition of the ataxia telangiectasia and Rad3-linked protein serine/threonine kinase (ATR; also referred to as FRAP-associated protein (FRP1)) has emerged like a promising tactic for cancer treatment that exploits artificial lethal interactions with proteins involved in DNA problems fix, overcomes resistance to other therapies and improves antitumour immunity. Various https://selisistat87653.fitnell.com/67320336/details-fiction-and-bms-394136